ABVC BioPharma, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ABVC BioPharma, Inc. on October 18, 2024. The report discloses a change in the company's independent registered public accounting firm. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol "ABVC".
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. However, it notes that the outgoing auditor's reports for the fiscal years ended December 31, 2023 and 2022, and the interim period through June 30, 2024, included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
Material Changes
- Termination of Prior Auditor: On October 10, 2024, WWC, P.C. ("WWC") agreed not to renew its engagement as the Company's independent registered public accounting firm. This decision was approved by the Board of Directors on October 17, 2024.
- Appointment of New Auditor: On October 17, 2024, the Board approved the engagement of Simon & Edward, LLP ("S&E") as the new independent registered public accounting firm.
- Audit History: There were no disagreements with WWC regarding accounting principles, financial statement disclosures, or auditing scope during the fiscal years 2022 and 2023, or the interim period through June 30, 2024.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the previously disclosed going concern uncertainty. The primary contingency noted is the pending receipt of a letter from WWC addressed to the SEC confirming their agreement with the statements made in this report; as of the filing date, WWC had not provided this letter.
Investor Verification Checklist
- Verify the status of the "substantial doubt about going concern" noted in prior audit reports.
- Monitor the filing of Exhibit 16.1 to confirm WWC's response letter regarding the change in auditors.
- Review the engagement terms and initial findings of the new auditor, Simon & Edward, LLP.
- Check for any subsequent filings that may address the reasons for the auditor change, as the filing states no disagreements occurred.